Describe the severe motor polyneuropathy secondary to the use of Vincristine in a patient with acute lymphoblastic leukemia in the period of April 2013.
1. Determine the sociodemographic characteristics of patients in study.
2. Identify the factors that favoured the onset of motor polyneuropathy secondary to the use of vincristine in the patient study.
3. To determine the clinical manifestations of the patient.
4. To describe the electrophysiological changes secondary motor polyneuropathy the use of vincristine in the patient study.
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2019 All rights reserved. iMedPub LTD Last revised : August 23, 2019